Michigan · 88188

Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers in Michigan

Michigan Medicare Avg
$47.89
1% below national avg
National Medicare Avg
$48.39
All states combined
Billed Charge (MI)
$269.57
What providers submit
Est. Commercial (MI)
$128.85
National avg: $138.37
Est. Cash / Self-Pay (MI)
$119.72
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

1.7K
Services in MI
85
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Michigan

Provider Medicare Services
Socec, Catherine M.D. $46.20 71
Cheng, Hong MD, PHD $52.93 34
Carey, John M.D. $49.30 20

Michigan Pricing in Context

In Michigan, CPT code 88188 (Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers) carries an average Medicare payment of $47.89 — 1% below the national benchmark of $48.39. 85 providers across the state submitted claims for this procedure in 2023, performing 1.7K total services. Individual payments in MI ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Michigan is $269.57, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Michigan sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Genetic/Molecular Test procedures, the estimated commercial insurance price in Michigan lands near $128.85, with self-pay cash prices typically around $119.72. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers cost in Michigan?

The average Medicare payment for Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers in Michigan is $47.89, which is 1% below the national average of $48.39. Providers in MI typically bill $269.57 for this procedure.

What does Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers cost with insurance in Michigan?

With commercial insurance in Michigan, Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers costs an estimated $128.85. Without insurance, the estimated cash price is $119.72. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers in Michigan?

85 providers in Michigan billed Medicare for Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers in 2023, performing 1.7K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers cheaper in Michigan than the national average?

Yes — Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers costs 1% below the national average in Michigan. The state average Medicare payment is $47.89 compared to $48.39 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial